BML-284
BML-284 (Wnt agonist 1) is a cell-permeable, selective small molecule that potently activates Wnt/β-catenin signaling. It is widely used in vitro to study stem cell biology, tissue regeneration, and oncogenesis, and has been applied in vivo within bone and cartilage research models.
Product Specifications
CAS Number
853220-52-7
Product Name Alternative
Betacatenin, beta-catenin, AGS, BML 284, BML284, BML-284, bcatenin, cardiac defect, E-cadherin, Inhibitor, malformed phenotype, inhibit, N-cadherin, MNK45, Wnt agonist 1, Wnt, Wnt/betacatenin, Wnt/b-catenin, Wnt/β-catenin, TCF, βcatenin
Field of Research
Signal Transduction, Stem Cell & Developmental Biology
Purity
99.66% (May vary between batches)
Solubility
DMSO:255 mg/mL (727.8 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ; Ethanol:< 1 mg/mL (insoluble or slightly soluble) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.71 mM)
Smiles
COc1cccc (c1) -c1cc (NCc2ccc3OCOc3c2) nc (N) n1
Molecular Formula
C19H18N4O3
Molecular Weight
350.37
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog